Healthpeak Properties (NYSE:DOC) Raised to Hold at Scotiabank

Healthpeak Properties (NYSE:DOC) was upgraded by stock analysts at Scotiabank to a “hold” rating in a report released on Thursday,Zacks.com reports.

A number of other brokerages have also commented on DOC. Citigroup decreased their price objective on shares of Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating on the stock in a report on Wednesday, April 1st. UBS Group began coverage on shares of Healthpeak Properties in a report on Monday. They set a “neutral” rating and a $17.00 price objective on the stock. Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Saturday, April 11th. Wells Fargo & Company reissued a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Finally, Argus lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Six research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of “Hold” and a consensus price target of $19.04.

Healthpeak Properties Stock Up 0.1%

DOC opened at $16.43 on Thursday. The firm’s 50-day simple moving average is $17.01 and its 200-day simple moving average is $17.24. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. Healthpeak Properties has a twelve month low of $15.71 and a twelve month high of $19.68. The firm has a market cap of $11.42 billion, a price-to-earnings ratio of 164.28, a PEG ratio of 2.26 and a beta of 1.10.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The firm had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. During the same quarter in the prior year, the firm earned $0.46 EPS. The company’s revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Equities research analysts anticipate that Healthpeak Properties will post 1.74 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Mather Group LLC. bought a new position in shares of Healthpeak Properties in the 3rd quarter valued at about $25,000. City Holding Co. bought a new position in shares of Healthpeak Properties in the 3rd quarter valued at about $26,000. WPG Advisers LLC boosted its stake in shares of Healthpeak Properties by 270.2% in the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 1,197 shares during the last quarter. Advocate Investing Services LLC bought a new position in shares of Healthpeak Properties in the 4th quarter valued at about $26,000. Finally, Elyxium Wealth LLC bought a new position in shares of Healthpeak Properties in the 4th quarter valued at about $31,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.